Palantir is charging full throttle into AI-driven defense and government operations with two headline initiatives. The ...

Analysts have handed AbbVie a consensus “Moderate Buy” rating, reflecting cautious optimism about its future performance. Out ...

Mizuho hiked its price target for AMD from $135 to $152 and kept its “outperform” rating, fueling investor optimism. Several ...

A securities class action targets UnitedHealth over alleged fraud hurting investors from December 2024 to April 2025. Levi & ...

Eli Lilly’s blockbuster GLP-1 drugs dominate headlines, but its broader portfolio deserves a standing ovation for driving ...

Lodestone Wealth Management trimmed its Home Depot stake by 14% in Q1, selling 708 shares, leaving 4,341 remaining. Several ...

Principal Financial Group reduced its Adobe stake by 8.3% in Q1, selling over 57,000 shares worth $242 million. Several ...

Strategic Blueprint LLC increased its Salesforce stake by 13.5% in Q1, reaching 23,828 shares worth $6.39 million. Hedge ...

First Horizon Advisors increased its holdings in Johnson & Johnson by 5% in the first quarter, adding over 12,000 shares.

Oracle is doubling down on cloud and AI to secure its future in an increasingly competitive tech market. The company reported ...

Calamos Advisors cranked up its PepsiCo investment by 24.8%, snagging nearly 247,000 shares worth about $37 million. Other ...

Alta Advisers significantly increased its JPMorgan Chase stake by 55.8% in Q1, acquiring an additional 5,200 shares. The firm ...